New Warnings for MS Drug Gilenya After FDA Review

April 20, 2012, 7:18 am by WebMD

Novartis, the maker of the drug Gilenya (fingolimod), a once-daily oral capsule taken for multiple sclerosis, has added stronger warnings to labels and prescription information about the drug’s possible heart risks, according to a company statement.


More from WebMD

Most States To Rely On Federal Website For 2015 Enrollment
WebMD : April 24, 2014, 11:45 am
Most States To Rely On Federal Website For 2015 Enrollment

FDA to Propose E-Cigarette Regulations
WebMD : April 24, 2014, 10:16 am
Opponents of the increasingly popular devices worry about their impact on children

1 in 13 U.S. Schoolkids Takes Psych Meds: Report
WebMD : April 24, 2014, 10:15 am
More than half of parents said the drugs are helpful

Vitamin D May Not Lower Seniors' Fall Risk
WebMD : April 24, 2014, 10:15 am
Researchers conclude there isn't enough evidence to support supplement use

Frozen as Good as Fresh for Fecal Transplants for Diarrhea: Study
WebMD : April 24, 2014, 10:15 am
Researchers looked at recurring infections caused by C. difficile bacteria


Wearable Tech! Here comes personal health optimization!

Fitbit Flex Sleep Sensor TrackerThe Fitbit Flex, a wearable sensor, is one of the more popular wearable tech devices for tracking your activity, diet, and even your sleep patterns. Oh, and you can throw away your alarm clock. You now have a silent alarm on your wrist; vibrates at your set wake time.

The Fitbit Flex is only $99. Learn more from the company below.

Learn More from Fitbit Inc
Check Amazon for Fitbit

Want more medical news headlines? You got it!

Inexpensive DNA Genetic TestingClick/touch below until you feel reading this much medical news is bad for your health ;)

Want medical news on your phone or tablet? Simply save www.medicalwebtimes.com to your home screen.

For the love of medical news!

Go To Medical News!
Go To Medical Search!